Electrosurgery Market

The electrosurgery market is projected to reach USD 11.59 billion by 2031 from USD 8.01 billion in 2025, at a CAGR of 6.4% during the forecast period.

The electrosurgery market is significantly driven by the rising prevalence of chronic diseases, including cancer, cardiovascular disorders, and gastrointestinal conditions. These diseases increase the need for surgical interventions. Additionally, the growing demand for minimally invasive surgeries (MIS) is accelerating the adoption of electrosurgical devices. These devices enable high-precision procedures with reduced blood loss, shorter hospital stays, and faster recovery. Increased government healthcare funding is a key catalyst for upgrading hospital infrastructure and introducing advanced surgical technologies. Moreover, rising cosmetic and bariatric surgeries, driven by lifestyle changes, increased obesity, and greater aesthetic consciousness, are leading procedure volumes in both hospitals and ambulatory settings. Together, these factors continue to create a favorable environment for technological advancements in electrosurgery systems and sustained demand over the long term.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the electrosurgery market include Medtronic (Ireland), Johnson & Johnson (US), Conmed Corporation (US), B Braun SE (Germany), Erbe Elektromedizin GmbH (Germany), Olympus Corporation (Japan), BOWA-electronic GmbH & Co. KG (Germany), Boston Scientific (US), and other players.

Leading players in the global electrosurgery market strengthen their competitive positions through continuous innovation, expansion, partnerships, and strategic collaborations. These companies are increasing R&D investments to develop ergonomically advanced and technologically enhanced electrosurgical systems that improve procedural safety and efficiency. To extend their global footprint, market participants pursue partnerships and acquisitions, enabling product portfolio diversification and access to new healthcare systems. In addition, many firms adopt organic strategies, such as launching products and securing approvals from regulatory authorities, including the US Food and Drug Administration, the European Medicines Agency (EMA), and national health agencies. Collectively, these initiatives enhance competitiveness, address evolving surgical demands, and support a strong market presence across the region.

• In September 2025, Medtronic announced the launch of two advanced surgical energy generators in India under the Valleylab™ FT10 series, the Valleylab™ FT10 Electrosurgical Generator (VLFT10FXGEN) and the Valleylab™ FT10 Vessel Sealing Generator (VLFT10LSGEN).
•  In March 2025, Johnson & Johnson MedTech announced the launch of the DUALTO™ Energy System, a surgical solution that integrates multiple energy modalities into an integrated platform for use in open and minimally invasive surgery. 
• In February 2025: BOWA MEDICAL UK announced a key milestone in the development of its new Kingskerswell headquarters, signaling progress in the company’s long-term expansion strategy. The upcoming facility is expected to substantially strengthen BOWA’s operational capacity and enable the company to better meet rising demand for its electrosurgical products across the UK market.

Medtronic (Ireland)

The electrosurgery market is significantly driven by the rising prevalence of chronic diseases, including cancer, cardiovascular disorders, and gastrointestinal conditions. These diseases increase the need for surgical interventions. Additionally, the growing demand for minimally invasive surgeries (MIS) is accelerating the adoption of electrosurgical devices. These devices enable high-precision procedures with reduced blood loss, shorter hospital stays, and faster recovery. Increased government healthcare funding is a key catalyst for upgrading hospital infrastructure and introducing advanced surgical technologies. Moreover, rising cosmetic and bariatric surgeries, driven by lifestyle changes, increased obesity, and greater aesthetic consciousness, are leading procedure volumes in both hospitals and ambulatory settings. Together, these factors continue to create a favorable environment for technological advancements in electrosurgery systems and sustained demand over the long term.

Johnson & Johnson (US)

Johnson & Johnson is a major player in the global electrosurgery market, driven by its extensive geographic reach, a well-rounded surgical product portfolio, and a constant dedication to innovation. Through its Ethicon branch, the company provides a complete range of electrosurgical instruments, generators, accessories, and smoke evacuation systems. The company has a presence worldwide through several subsidiaries, including Cordis Corporation (US), DePuy, Inc. (US), Ethicon, Inc. (US), and Johnson & Johnson Japan Inc. (Japan). This extensive subsidiary network allows the company to be very close to customers and to have a deep understanding of local surgical needs. The company invests heavily in research and development. For instance, in 2024 the R&D budget was USD 17.2 billion. In 2025, the company launched the DUALTO Energy System, an electrosurgical generator with a streamlined user interface, Polyphonic Fleet digital device management, and support for monopolar, bipolar, ultrasonic, and advanced bipolar energy applications in both open and minimally invasive surgeries. Such a robust innovation pipeline, together with an extensive regional presence, cements Johnson & Johnson’s position as a global leader in electrosurgery.

MARKET RANKING

Medtronic (Ireland) is one of the leading players in the global electrosurgery market. The company benefits from a broad and diversified product range that includes electrosurgical instruments, generators, accessories, and smoke evacuation systems. Moreover, its solid worldwide distribution network and consistent R&D investments provide strong support for its market leadership. Johnson & Johnson (US) is the next in line, largely due to its stronghold in electrosurgical instruments, generators, and accessories. Olympus Corporation (Japan) is also a major player in the market, with its market share partly explained by a wide range of electrosurgical generators, instruments, accessories, smoke management systems, and a strong global presence. B. Braun SE (Germany) has a somewhat moderate market position, mainly the result of its range of monopolar and bipolar accessories as well as other electrosurgical products. ConMed Corporation (US) is a notable player in the electrosurgery market, mainly due to its strengths in electrosurgical generators, accessories, and smoke evacuation systems.

Related Reports:

Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com